{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T19:00:03Z","timestamp":1793041203729,"version":"4.5.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,7]],"date-time":"2025-08-07T00:00:00Z","timestamp":1754524800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,8,7]],"date-time":"2025-08-07T00:00:00Z","timestamp":1754524800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Research Council of Finland\u2019s Flagship InFLAMES","award":["337530, 357910 and 358823"],"award-info":[{"award-number":["337530, 357910 and 358823"]}],"id":[{"id":"https:\/\/ror.org\/05k73zm37","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Research Council of Finland\u2019s Flagship InFLAMES","award":["337530, 357910 and 358823"],"award-info":[{"award-number":["337530, 357910 and 358823"]}],"id":[{"id":"https:\/\/ror.org\/05k73zm37","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Research Council of Finland\u2019s Flagship InFLAMES","award":["337530, 357910 and 358823"],"award-info":[{"award-number":["337530, 357910 and 358823"]}],"id":[{"id":"https:\/\/ror.org\/05k73zm37","id-type":"ROR","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100003125","name":"Suomen Kulttuurirahasto","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003125","id-type":"DOI","asserted-by":"publisher"}]},{"name":"University of Turku Drug Research Doctoral Programme","id":[{"id":"https:\/\/ror.org\/05vghhr25","id-type":"ROR","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100002341","name":"Research Council of Finland","doi-asserted-by":"publisher","award":["330902"],"award-info":[{"award-number":["330902"]}],"id":[{"id":"10.13039\/501100002341","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004012","name":"Jane ja Aatos Erkon S\u00e4\u00e4ti\u00f6","doi-asserted-by":"publisher","award":["#220026"],"award-info":[{"award-number":["#220026"]}],"id":[{"id":"10.13039\/501100004012","id-type":"DOI","asserted-by":"publisher"}]},{"name":"National MS Society and the National Stem Cell Foundation","award":["RFA-2203-39281"],"award-info":[{"award-number":["RFA-2203-39281"]}],"id":[{"id":"https:\/\/ror.org\/03019wv17","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neuroinflammation"],"DOI":"10.1186\/s12974-025-03519-y","type":"journal-article","created":{"date-parts":[[2025,8,7]],"date-time":"2025-08-07T12:37:16Z","timestamp":1754570236000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Longitudinal accumulation of glial activation measured by TSPO-PET predicts later brain atrophy in multiple sclerosis"],"prefix":"10.1186","volume":"22","author":[{"given":"Marjo","family":"Nylund","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jussi","family":"Lehto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus","family":"Matilainen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johan","family":"Rajander","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saara","family":"Wahlroos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcus","family":"Sucksdorff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanja","family":"Kuhlmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Airas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,7]]},"reference":[{"key":"3519_CR1","doi-asserted-by":"publisher","unstructured":"Miller DH, Hornabrook RW, Purdie G. The natural history of multiple sclerosis: a regional study with some longitudinal data. Neurosurgery, and Psychiatry. 1992;55:341\u20136. Available from: https:\/\/doi.org\/10.1136\/jnnp.55.5.341","DOI":"10.1136\/jnnp.55.5.341"},{"key":"3519_CR2","doi-asserted-by":"crossref","unstructured":"Reich DS, Lucchinetti CF, Calabresi PA. Multiple Sclerosis. New England Journal of Medicine. 2018;378:169\u201380. Available from: https:\/\/www.nejm.org\/doi\/full\/10.1056\/NEJMra1401483","DOI":"10.1056\/NEJMra1401483"},{"key":"3519_CR3","doi-asserted-by":"crossref","unstructured":"Giovannoni G, Popescu V, Wuerfel J, Hellwig K, Iacobeus E, Jensen MB et al. Smouldering multiple sclerosis: the \u2018real MS.\u2019 Ther Adv Neurol Disord. 2022;15. Available from: https:\/\/journals.sagepub.com\/doi\/10.1177\/17562864211066751","DOI":"10.1177\/17562864211066751"},{"key":"3519_CR4","doi-asserted-by":"publisher","unstructured":"Bagnato F, Sati P, Hemond CC, Elliott C, Gauthier SA, Harrison DM et al. Imaging chronic active lesions in multiple sclerosis: a consensus statement. Brain. 2024;27. Available from: https:\/\/doi.org\/10.1093\/brain\/awae013","DOI":"10.1093\/brain\/awae013"},{"key":"3519_CR5","doi-asserted-by":"publisher","unstructured":"Hamzaoui M, Garcia J, Boffa G, Lazzarotto A, Absinta M, Ricigliano VAG et al. Positron Emission Tomography with [18F]-DPA-714 Unveils a Smoldering Component in Most Multiple Sclerosis Lesions which Drives Disease Progression. Ann Neurol. 2023;94:366\u201383. Available from: https:\/\/doi.org\/10.1002\/ana.26657","DOI":"10.1002\/ana.26657"},{"key":"3519_CR6","doi-asserted-by":"crossref","unstructured":"Kuhlmann T, Ludwin S, Prat A, Antel J, Br\u00fcck W, Lassmann H. An updated histological classification system for multiple sclerosis lesions. Acta Neuropathol. 2017;133:13\u201324. Available from: https:\/\/link.springer.com\/article\/10.1007\/s00401-016-1653-y","DOI":"10.1007\/s00401-016-1653-y"},{"key":"3519_CR7","unstructured":"Klotz L, Smolders J, Lehto J, Matilainen M, L\u00fctje L, Buchholz L et al. Broad rim lesions are a new pathological and imaging biomarker for rapid disease progression in multiple sclerosis. Nat Med. 2025;14:1\u201311. Available from: https:\/\/www.nature.com\/articles\/s41591-025-03625-7"},{"key":"3519_CR8","doi-asserted-by":"crossref","unstructured":"Chauveau F, Becker G, Boutin H. Have (R)-[11\u00a0C]PK11195 challengers fulfilled the promise? A scoping review of clinical TSPO PET studies. Eur J Nucl Med Mol Imaging. 2021;49:201\u201320. Available from: https:\/\/link.springer.com\/article\/10.1007\/s00259-021-05425-w","DOI":"10.1007\/s00259-021-05425-w"},{"key":"3519_CR9","doi-asserted-by":"publisher","unstructured":"Sucksdorff M, Matilainen M, Tuisku J, Polvinen E, Vuorimaa A, Rokka J et al. Brain TSPO-PET predicts later disease progression independent of relapses in multiple sclerosis. Brain. 2020;143:3318\u201330. Available from: https:\/\/doi.org\/10.1093\/brain\/awaa275","DOI":"10.1093\/brain\/awaa275"},{"key":"3519_CR10","doi-asserted-by":"publisher","unstructured":"Misin O, Matilainen M, Nylund M, Honkonen E, Rissanen E, Sucksdorff M et al. Innate Immune Cell-Related Pathology in the Thalamus Signals a Risk for Disability Progression in Multiple Sclerosis. Neurol Neuroimmunol Neuroinflamm. 2022;9. Available from: https:\/\/doi.org\/10.1212\/NXI.0000000000001182","DOI":"10.1212\/NXI.0000000000001182"},{"key":"3519_CR11","doi-asserted-by":"publisher","unstructured":"Polvinen E, Matilainen M, Nylund M, Sucksdorff M, Airas LM. TSPO-Detectable Chronic Active Lesions Predict Disease Progression in Multiple Sclerosis. Neurology(R) neuroimmunology & neuroinflammation. 2023;10. Available from: https:\/\/doi.org\/10.1212\/NXI.0000000000200133","DOI":"10.1212\/NXI.0000000000200133"},{"key":"3519_CR12","doi-asserted-by":"crossref","unstructured":"Airas L, Yong VW. Microglia in multiple sclerosis - Pathogenesis and imaging. Curr Opin Neurol. 2022;35:299\u2013306. Available from: https:\/\/journals.lww.com\/co-neurology\/fulltext\/2022\/06000\/microglia_in_multiple_sclerosis___pathogenesis_and.8.aspx","DOI":"10.1097\/WCO.0000000000001045"},{"key":"3519_CR13","doi-asserted-by":"crossref","unstructured":"Lehto J, Sucksdorff M, Nylund M, Raitanen R, Matilainen M, Airas L. PET-measurable innate immune cell activation reduction in chronic active lesions in PPMS brain after rituximab treatment: a case report. J Neurol. 2023;270:2329\u201332. Available from: https:\/\/link.springer.com\/article\/10.1007\/s00415-022-11539-4","DOI":"10.1007\/s00415-022-11539-4"},{"key":"3519_CR14","doi-asserted-by":"publisher","unstructured":"Sucksdorff M, Tuisku J, Matilainen M, Vuorimaa A, Smith S, Keitil\u00e4 J et al. Natalizumab treatment reduces microglial activation in the white matter of the MS brain. Neurol Neuroimmunol Neuroinflamm. 2019;6. Available from: https:\/\/doi.org\/10.1212\/NXI.0000000000000574","DOI":"10.1212\/NXI.0000000000000574"},{"key":"3519_CR15","doi-asserted-by":"publisher","unstructured":"Kalincik T, Cutter G, Spelman T, Jokubaitis V, Havrdova E, Horakova D et al. Defining reliable disability outcomes in multiple sclerosis. Brain. 2015;138:3287\u201398. Available from: https:\/\/doi.org\/10.1093\/brain\/awv258","DOI":"10.1093\/brain\/awv258"},{"key":"3519_CR16","doi-asserted-by":"publisher","unstructured":"Schmidt P, Gaser C, Arsic M, Buck D, F\u00f6rschler A, Berthele A et al. An automated tool for detection of FLAIR-hyperintense white-matter lesions in Multiple Sclerosis. Neuroimage. 2012;59:3774\u201383. Available from: https:\/\/doi.org\/10.1016\/j.neuroimage.2011.11.032","DOI":"10.1016\/j.neuroimage.2011.11.032"},{"key":"3519_CR17","doi-asserted-by":"publisher","unstructured":"Nylund M, Sucksdorff M, Matilainen M, Polvinen E, Tuisku J, Airas L. Phenotyping of multiple sclerosis lesions according to innate immune cell activation using 18\u00a0kDa translocator protein-PET. Brain Commun. 2022;4. Available from: https:\/\/doi.org\/10.1093\/braincomms\/fcab301","DOI":"10.1093\/braincomms\/fcab301"},{"key":"3519_CR18","doi-asserted-by":"publisher","unstructured":"Smith SM, Zhang Y, Jenkinson M, Chen J, Matthews PM, Federico A et al. Accurate, Robust, and Automated Longitudinal and Cross-Sectional Brain Change Analysis. Neuroimage. 2002;17:479\u201389. Available from: https:\/\/doi.org\/10.1006\/nimg.2002.1040","DOI":"10.1006\/nimg.2002.1040"},{"key":"3519_CR19","doi-asserted-by":"publisher","unstructured":"Smith SM, Jenkinson M, Woolrich MW, Beckmann CF, Behrens TEJ, Johansen-Berg H et al. Advances in functional and structural MR image analysis and implementation as FSL. Neuroimage. 2004;23:S208\u201319. Available from: https:\/\/doi.org\/10.1016\/j.neuroimage.2004.07.051","DOI":"10.1016\/j.neuroimage.2004.07.051"},{"key":"3519_CR20","doi-asserted-by":"crossref","unstructured":"Lehto J, Nylund M, Matilainen M, Sucksdorff M, Vuorimaa A, Rajander J et al. Longitudinal stability of progression-related microglial activity during teriflunomide treatment in patients with multiple sclerosis. Eur J Neurol. 2023;30:2365\u201375. Available from: https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1111\/ene.15834","DOI":"10.1111\/ene.15834"},{"key":"3519_CR21","doi-asserted-by":"publisher","unstructured":"Alakurtti K, Aalto S, Johansson JJ, N\u00e5gren K, Tuokkola T, Oikonen V et al. Reproducibility of striatal and thalamic dopamine D2 receptor binding using 11 Craclopride with high-resolution positron emission tomography. Journal of Cerebral Blood Flow and Metabolism. 2011;31:155\u201365. Available from: https:\/\/doi.org\/10.1038\/jcbfm.2010.64","DOI":"10.1038\/jcbfm.2010.64"},{"key":"3519_CR22","doi-asserted-by":"publisher","unstructured":"Logan J, Fowler JS, Volkow ND, Wang G-J, Ding Y-S, Alexoff DL. Distribution Volume Ratios without Blood Sampling from Graphical Analysis of PET Data. Journal of Cerebral Blood Flow & Metabolism. 1996;16:834\u201340. Available from: https:\/\/doi.org\/10.1097\/00004647-199609000-00008","DOI":"10.1097\/00004647-199609000-00008"},{"key":"3519_CR23","doi-asserted-by":"publisher","unstructured":"Meguro R, Asano Y, Odagiri S, Li C, Iwatsuki H, Shoumura K. Nonheme-iron histochemistry for light and electron microscopy: a historical, theoretical and technical review. Arch Histol Cytol. 2007;70:1\u201319. Available from: https:\/\/doi.org\/10.1679\/aohc.70.1","DOI":"10.1679\/aohc.70.1"},{"key":"3519_CR24","doi-asserted-by":"publisher","unstructured":"Gelman A. Scaling regression inputs by dividing by two standard deviations. Stat Med. 2008;27:2865\u201373. Available from: https:\/\/doi.org\/10.1002\/sim.3107","DOI":"10.1002\/sim.3107"},{"key":"3519_CR25","doi-asserted-by":"crossref","unstructured":"Frischer JM, Weigand SD, Guo Y, Kale N, Parisi JE, Pirko I et al. Clinical and pathological insights into the dynamic nature of the white matter multiple sclerosis plaque. Ann Neurol. 2015;78:710\u201321. Available from: https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1002\/ana.24497","DOI":"10.1002\/ana.24497"},{"key":"3519_CR26","doi-asserted-by":"publisher","unstructured":"Kaunzner UW, Kang Y, Monohan E, Kothari PJ, Nealon N, Perumal J et al. Reduction of PK11195 uptake observed in multiple sclerosis lesions after natalizumab initiation. Mult Scler Relat Disord. 2017;15:27\u201333. Available from: https:\/\/doi.org\/10.1016\/j.msard.2017.04.008","DOI":"10.1016\/j.msard.2017.04.008"},{"key":"3519_CR27","doi-asserted-by":"publisher","unstructured":"Ratchford JN, Endres CJ, Hammoud DA, Pomper MG, Shiee N, McGready J et al. Decreased microglial activation in MS patients treated with glatiramer acetate. J Neurol. 2011;259:1199. Available from: https:\/\/doi.org\/10.1007\/s00415-011-6337-x","DOI":"10.1007\/s00415-011-6337-x"},{"key":"3519_CR28","doi-asserted-by":"crossref","unstructured":"Ward MA, Carlsson CM, Trivedi MA, Sager MA, Johnson SC. The effect of body mass index on global brain volume in middle-aged adults: A cross sectional study. BMC Neurol. 2005;5:1\u20137. Available from: https:\/\/bmcneurol.biomedcentral.com\/articles\/10.1186\/1471-2377-5-23","DOI":"10.1186\/1471-2377-5-23"},{"key":"3519_CR29","doi-asserted-by":"crossref","unstructured":"Tuisku J, Plav\u00e9n-Sigray P, Gaiser EC, Airas L, Al-Abdulrasul H, Br\u00fcck A et al. Effects of age, BMI and sex on the glial cell marker TSPO \u2014 a multicentre [11\u00a0C]PBR28 HRRT PET study. Eur J Nucl Med Mol Imaging. 2019;46:2329\u201338. Available from: https:\/\/link.springer.com\/10.1007\/s00259-019-04403-7","DOI":"10.1007\/s00259-019-04403-7"},{"key":"3519_CR30","doi-asserted-by":"publisher","unstructured":"Nutma E, Stephenson JA, Gorter RP, De Bruin J, Boucherie DM, Donat CK et al. A quantitative neuropathological assessment of translocator protein expression in multiple sclerosis. Brain. 2019;142:3440\u201355. Available from: https:\/\/doi.org\/10.1093\/brain\/awz287","DOI":"10.1093\/brain\/awz287"}],"updated-by":[{"DOI":"10.1186\/s12974-026-03700-x","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T00:00:00Z","timestamp":1769990400000}}],"container-title":["Journal of Neuroinflammation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12974-025-03519-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12974-025-03519-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12974-025-03519-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T06:34:21Z","timestamp":1770014061000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12974-025-03519-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,7]]},"references-count":30,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3519"],"URL":"https:\/\/doi.org\/10.1186\/s12974-025-03519-y","relation":{},"ISSN":["1742-2094"],"issn-type":[{"value":"1742-2094","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,7]]},"assertion":[{"value":"11 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 January 2026","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The given and family name of all the authors was corrected.","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 February 2026","order":8,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":9,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":10,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1186\/s12974-026-03700-x","URL":"https:\/\/doi.org\/10.1186\/s12974-026-03700-x","order":11,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The study protocol was approved by the Ethics Committee of the Hospital District of Southwest Finland (Dnro:76\/180\/2008 and Dnro:86\/1800\/2017). Written informed consent was obtained from all participants according to the principles of the Declaration of Helsinki. The study for postmortem neuropathological staining was approved by the Ethics Committee of the University of M\u00fcnster (Ref: 2011-153-f-S).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human ethics and consent to participate"}}],"article-number":"200"}}